Literature DB >> 20372051

Trypanosoma cruzi infection results in the reduced expression of caveolin-3 in the heart.

Daniel Adesse1, Michael P Lisanti, David C Spray, Fabiana S Machado, Maria de Nazareth Meirelles, Herbert B Tanowitz, Luciana Ribeiro Garzoni.   

Abstract

Caveolae are motile, membrane-bound compartments that contain a number of molecules that participate in cell signaling. Caveolins are protein markers of caveolae and function in a variety of biological processes. Caveolin-3 (Cav-3) is expressed in muscle cells and Cav-3 null mice display a cardiomyopathic phenotype. Ultrastructural cytochemistry, confocal microscopy and immunoblotting revealed a reduction in Cav-3 expression and an activation of ERK (extracellular-signal-regulated kinase) 48 hours after Trypanosoma cruzi infection of cultured cardiac myocytes. CD-1 mice infected with the Brazil strain of T. cruzi displayed reduced expression of Cav-3 and activation of ERK 66 days post infection (dpi).   By 180 dpi there was a normalization of these values. These data suggest that the reduction in Cav-3 expression and the activation of ERK during the early phase of infection may contribute to the pathogenesis of chagasic cardiomyopathy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20372051      PMCID: PMC3096707          DOI: 10.4161/cc.9.8.11509

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  38 in total

1.  Ignition of calcium sparks in arterial and cardiac muscle through caveolae.

Authors:  M Löhn; M Fürstenau; V Sagach; M Elger; W Schulze; F C Luft; H Haller; M Gollasch
Journal:  Circ Res       Date:  2000-11-24       Impact factor: 17.367

2.  Calcium sparks in human coronary artery smooth muscle cells resolved by confocal imaging.

Authors:  M Fürstenau; M Löhn; C Ried; F C Luft; H Haller; M Gollasch
Journal:  J Hypertens       Date:  2000-09       Impact factor: 4.844

3.  Caveolin-1 null mice develop cardiac hypertrophy with hyperactivation of p42/44 MAP kinase in cardiac fibroblasts.

Authors:  Alex W Cohen; David S Park; Scott E Woodman; Terrence M Williams; Madhulika Chandra; Jamshid Shirani; Andrea Pereira de Souza; Richard N Kitsis; Robert G Russell; Louis M Weiss; Baiyu Tang; Linda A Jelicks; Stephen M Factor; Vitaliy Shtutin; Herbert B Tanowitz; Michael P Lisanti
Journal:  Am J Physiol Cell Physiol       Date:  2002-10-09       Impact factor: 4.249

4.  Activation of transcription factors AP-1 and NF-kappa B in murine Chagasic myocarditis.

Authors:  Huan Huang; Stefka B Petkova; Alex W Cohen; Boumediene Bouzahzah; John Chan; Jian-nian Zhou; Stephen M Factor; Louis M Weiss; Mohan Krishnamachary; Shankar Mukherjee; Murray Wittner; Richard N Kitsis; Richard G Pestell; Michael P Lisanti; Chris Albanese; Herbert B Tanowitz
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

5.  Trypanosoma cruzi infection activates extracellular signal-regulated kinase in cultured endothelial and smooth muscle cells.

Authors:  Shankar Mukherjee; Huan Huang; Stefka B Petkova; Chris Albanese; Richard G Pestell; Vicki L Braunstein; George J Christ; Murray Wittner; Michael P Lisanti; Joan W Berman; Louis M Weiss; Herbert B Tanowitz
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

6.  Characterization of [Ca2+]i responses in primary cultures of mouse cardiomyocytes induced by Trypanosoma cruzi trypomastigotes.

Authors:  Luciana R Garzoni; Masako Oya Masuda; Márcia M Capella; Anibal Gil Lopes; Maria de Nazareth S Leal de Meirelles
Journal:  Mem Inst Oswaldo Cruz       Date:  2003-08-18       Impact factor: 2.743

7.  Caveolin-3 knock-out mice develop a progressive cardiomyopathy and show hyperactivation of the p42/44 MAPK cascade.

Authors:  Scott E Woodman; David S Park; Alex W Cohen; Michelle W-C Cheung; Madhulika Chandra; Jamshid Shirani; Baiyu Tang; Linda A Jelicks; Richard N Kitsis; George J Christ; Stephen M Factor; Herbert B Tanowitz; Michael P Lisanti
Journal:  J Biol Chem       Date:  2002-07-23       Impact factor: 5.157

8.  Caveolin-1/3 double-knockout mice are viable, but lack both muscle and non-muscle caveolae, and develop a severe cardiomyopathic phenotype.

Authors:  David S Park; Scott E Woodman; William Schubert; Alex W Cohen; Philippe G Frank; Madhulika Chandra; Jamshid Shirani; Babak Razani; Baiyu Tang; Linda A Jelicks; Stephen M Factor; Louis M Weiss; Herbert B Tanowitz; Michael P Lisanti
Journal:  Am J Pathol       Date:  2002-06       Impact factor: 4.307

Review 9.  Perspectives on Trypanosoma cruzi-induced heart disease (Chagas disease).

Authors:  Herbert B Tanowitz; Fabiana S Machado; Linda A Jelicks; Jamshid Shirani; Antonio C Campos de Carvalho; David C Spray; Stephen M Factor; Louis V Kirchhoff; Louis M Weiss
Journal:  Prog Cardiovasc Dis       Date:  2009 May-Jun       Impact factor: 8.194

10.  Selective in vitro effects of the farnesyl pyrophosphate synthase inhibitor risedronate on Trypanosoma cruzi.

Authors:  Luciana R Garzoni; Aura Caldera; Maria de Nazareth L Meirelles; Solange L de Castro; Roberto Docampo; Gary A Meints; Eric Oldfield; Julio A Urbina
Journal:  Int J Antimicrob Agents       Date:  2004-03       Impact factor: 5.283

View more
  11 in total

Review 1.  Chagas heart disease: report on recent developments.

Authors:  Fabiana S Machado; Linda A Jelicks; Louis V Kirchhoff; Jamshid Shirani; Fnu Nagajyothi; Shankar Mukherjee; Randin Nelson; Christina M Coyle; David C Spray; Antonio C Campos de Carvalho; Fangxia Guan; Cibele M Prado; Michael P Lisanti; Louis M Weiss; Susan P Montgomery; Herbert B Tanowitz
Journal:  Cardiol Rev       Date:  2012 Mar-Apr       Impact factor: 2.644

2.  Curcumin treatment provides protection against Trypanosoma cruzi infection.

Authors:  Fnu Nagajyothi; Dazhi Zhao; Louis M Weiss; Herbert B Tanowitz
Journal:  Parasitol Res       Date:  2012-01-04       Impact factor: 2.289

3.  Matrix metalloproteinases 2 and 9 are differentially expressed in patients with indeterminate and cardiac clinical forms of Chagas disease.

Authors:  Rafaelle Christine Gomes Fares; Juliana de Assis Silva Gomes; Luciana Ribeiro Garzoni; Mariana Caldas Waghabi; Roberto Magalhães Saraiva; Nayara Ingrid Medeiros; Roberta Oliveira-Prado; Luiz Henrique Conde Sangenis; Mayara da Costa Chambela; Fernanda Fortes de Araújo; Andréa Teixeira-Carvalho; Marcos Paulo Damásio; Vanessa Azevedo Valente; Karine Silvestre Ferreira; Giovane Rodrigo Sousa; Manoel Otávio da Costa Rocha; Rodrigo Correa-Oliveira
Journal:  Infect Immun       Date:  2013-07-15       Impact factor: 3.441

Review 4.  Recent developments in the interactions between caveolin and pathogens.

Authors:  Fabiana S Machado; Nilda E Rodriguez; Daniel Adesse; Luciana R Garzoni; Lisia Esper; Michael P Lisanti; Robert D Burk; Chris Albanese; Koenraad Van Doorslaer; Louis M Weiss; Fnu Nagajyothi; Joshua D Nosanchuk; Mary E Wilson; Herbert B Tanowitz
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

Review 5.  Current understanding of immunity to Trypanosoma cruzi infection and pathogenesis of Chagas disease.

Authors:  Fabiana S Machado; Walderez O Dutra; Lisia Esper; Kenneth J Gollob; Mauro M Teixeira; Stephen M Factor; Louis M Weiss; Fnu Nagajyothi; Herbert B Tanowitz; Nisha J Garg
Journal:  Semin Immunopathol       Date:  2012-10-18       Impact factor: 9.623

Review 6.  Biomarkers of therapeutic responses in chronic Chagas disease: state of the art and future perspectives.

Authors:  Maria-Jesus Pinazo; Maria-Carmen Thomas; Juan Bustamante; Igor Correia de Almeida; Manuel-Carlos Lopez; Joaquim Gascon
Journal:  Mem Inst Oswaldo Cruz       Date:  2015-04-28       Impact factor: 2.743

7.  Endothelial transmigration by Trypanosoma cruzi.

Authors:  Bria M Coates; David P Sullivan; Ming Y Makanji; Nga Y Du; Cheryl L Olson; William A Muller; David M Engman; Conrad L Epting
Journal:  PLoS One       Date:  2013-12-02       Impact factor: 3.240

Review 8.  The Einstein-Brazil Fogarty: A decade of synergy.

Authors:  Joshua D Nosanchuk; Murphy D Nosanchuk; Marcio L Rodrigues; Leonardo Nimrichter; Antonio C Campos de Carvalho; Louis M Weiss; David C Spray; Herbert B Tanowitz
Journal:  Braz J Microbiol       Date:  2015 Oct-Dec       Impact factor: 2.476

9.  Trypanosoma cruzi Promotes Transcriptomic Remodeling of the JAK/STAT Signaling and Cell Cycle Pathways in Myoblasts.

Authors:  Lindice M Nisimura; Laura L Coelho; Tatiana G de Melo; Paloma de Carvalho Vieira; Pedro H Victorino; Luciana R Garzoni; David C Spray; Dumitru A Iacobas; Sanda Iacobas; Herbert B Tanowitz; Daniel Adesse
Journal:  Front Cell Infect Microbiol       Date:  2020-06-17       Impact factor: 5.293

10.  Pathogenesis of Chronic Chagas Disease: Macrophages, Mitochondria, and Oxidative Stress.

Authors:  Marcos Lopez; Herbert B Tanowitz; Nisha J Garg
Journal:  Curr Clin Microbiol Rep       Date:  2018-01-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.